Carl-Erik Nord

Publications
Public outreach and news

Articles

Journal article: VALUE IN HEALTH. 2018;21(4):441-448

The CDI-DaySyms: Content Development of a New Patient-Reported Outcome Questionnaire for Symptoms of Clostridium difficile Infection.

Kleinman L; Talbot GH; Hunsche E; Schüler R; Nord CE
Article: ANAEROBE. 2016;38:97-102

Clostridium difficile recurrences in Stockholm.

Sandell S; Rashid M-U; Jorup-Rönström C; Ellström K; Nord CE; Weintraub A
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2016;71(1):213-219

Susceptibility of Clostridium difficile isolates from a Phase 2 clinical trial of cadazolid and vancomycin in C. difficile infection.

Gerding DN; Hecht DW; Louie T; Nord CE; Talbot GH; Cornely OA; Buitrago M; Best E; Sambol S; Osmolski JR; Kracker H; Locher HH; Charef P; Wilcox M
Article: MBIO. 2015;6(6):e01693-e01615

Same Exposure but Two Radically Different Responses to Antibiotics: Resilience of the Salivary Microbiome versus Long-Term Microbial Shifts in Feces.

Zaura E; Brandt BW; Teixeira de Mattos MJ; Buijs MJ; Caspers MPM; Rashid M-U; Weintraub A; Nord CE; Savell A; Hu Y; Coates AR; Hubank M; Spratt DA; Wilson M; Keijser BJF; Crielaard W
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2015;59(10):6266-6273

Multicenter, Double-Blind, Randomized, Phase 2 Study Evaluating the Novel Antibiotic Cadazolid in Patients with Clostridium difficile Infection.

Louie T; Nord CE; Talbot GH; Wilcox M; Gerding DN; Buitrago M; Kracker H; Charef P; Cornely OA
Article: CLINICAL MICROBIOLOGY AND INFECTION. 2015;21(8):767.e1-767.e4

Analysis of effects of MCB3681, the antibacterially active substance of prodrug MCB3837, on human resident microflora as proof of principle.

Dalhoff A; Rashid M-U; Kapsner T; Panagiotidis G; Weintraub A; Nord CE
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2015;59(8):4504-4509

Ecological Effect of Ceftaroline-Avibactam on the Normal Human Intestinal Microbiota.

Rashid M-U; Rosenborg S; Panagiotidis G; Söderberg-Löfdal K; Weintraub A; Nord CE
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2015;59(8):4410-4416

Impact of Ciprofloxacin and Clindamycin Administration on Gram-Negative Bacteria Isolated from Healthy Volunteers and Characterization of the Resistance Genes They Harbor.

Card RM; Mafura M; Hunt T; Kirchner M; Weile J; Rashid M-U; Weintraub A; Nord CE; Anjum MF
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2015;46(1):60-65

Ecological effect of ceftazidime/avibactam on the normal human intestinal microbiota.

Rashid M-U; Rosenborg S; Panagiotidis G; Löfdal KS; Weintraub A; Nord CE
Article: CLINICAL INFECTIOUS DISEASES. 2015;60 Suppl 2:S77-S84

Determining the Long-term Effect of Antibiotic Administration on the Human Normal Intestinal Microbiota Using Culture and Pyrosequencing Methods.

Rashid M-U; Zaura E; Buijs MJ; Keijser BJF; Crielaard W; Nord CE; Weintraub A
Article: ANAEROBE. 2015;31:72-77

Development of antimicrobial resistance in the normal anaerobic microbiota during one year after administration of clindamycin or ciprofloxacin.

Rashid M-U; Weintraub A; Nord CE
Article: ANAEROBE. 2014;30:65-69

Risk factors of Clostridium difficile infections among patients in a university hospital in Shanghai, China.

Huang H; Wu S; Chen R; Xu S; Fang H; Weintraub A; Nord CE
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2014;44(2):125-130

Ecological impact of MCB3837 on the normal human microbiota.

Rashid M-U; Dalhoff A; Bäckström T; Björkhem-Bergman L; Panagiotidis G; Weintraub A; Nord CE
Article: ANAEROBE. 2014;28:216-219

In vitro activity of MCB3681 against Clostridium difficile strains.

Rashid M-U; Dalhoff A; Weintraub A; Nord CE
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 2014;52(1):173-179

Toxin-producing Clostridium difficile strains as long-term gut colonizers in healthy infants.

Adlerberth I; Huang H; Lindberg E; Åberg N; Hesselmar B; Saalman R; Nord CE; Wold AE; Weintraub A
Article: ANAEROBE. 2013;20:32-35

In vitro activity of cadazolid against Clostridium difficile strains isolated from primary and recurrent infections in Stockholm, Sweden.

Rashid M-U; Lozano HM; Weintraub A; Nord CE
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2013;41(4):352-357

Ecological impact of doxycycline at low dose on normal oropharyngeal and intestinal microflora.

Rashid M-U; Panagiotidis G; Bäckström T; Weintraub A; Nord CE
Article: CLINICAL MICROBIOLOGY AND INFECTION. 2012;18(9):E347-E354

Antibiotic resistance patterns of Escherichia coli isolates from different aquatic environmental sources in León, Nicaragua.

Amaya E; Reyes D; Paniagua M; Calderón S; Rashid M-U; Colque P; Kühn I; Möllby R; Weintraub A; Nord CE
Article: ANAEROBE. 2012;18(2):249-253

Effect of new antimicrobial agents on the ecological balance of human microflora.

Rashid M-U; Weintraub A; Nord CE
Article: PLOS ONE. 2012;7(7):e41480

An expanded multilocus sequence typing scheme for propionibacterium acnes: investigation of 'pathogenic', 'commensal' and antibiotic resistant strains.

McDowell A; Barnard E; Nagy I; Gao A; Tomida S; Li H; Eady A; Cove J; Nord CE; Patrick S
Article: INFECTION. 2011;39(6):571-574

Cellulose and PapG are important for Escherichia coli causing recurrent urinary tract infection in women.

Norinder BS; Lüthje P; Yadav M; Kadas L; Fang H; Nord CE; Brauner A
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2011;38(6):474-479

Effect of telavancin on human intestinal microflora.

Rashid M-U; Weintraub A; Nord CE
Article: JOURNAL OF CHEMOTHERAPY. 2011;23(3):145-149

Comparative effects of the immediate and the extended release formulations of ciprofloxacin on normal human intestinal microflora.

Rashid M; Weintraub A; Nord CE
Article: FEMS MICROBIOLOGY LETTERS. 2011;319(2):125-132

The role of Bacteroides fragilis RecQ DNA helicases in cell survival after metronidazole exposure.

Paul L; Patrick S; Nord CE; Abratt V
Article: CLINICAL MICROBIOLOGY AND INFECTION. 2011;17(3):371-379

Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience.

Nagy E; Urbán E; Nord CE; ESCMID Study Group on Antimicrobial Resistance in
Article: JOURNAL OF MEDICAL MICROBIOLOGY. 2011;60(Pt 2):216-222

Antibiotic resistance patterns of intestinal Escherichia coli isolates from Nicaraguan children.

Amaya E; Reyes D; Vilchez S; Paniagua M; Möllby R; Nord CE; Weintraub A
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2010;36(6):537-541

Effect of ceftobiprole on the normal human intestinal microflora.

Bäckström T; Panagiotidis G; Beck O; Asker-Hagelberg C; Rashid M-U; Weintraub A; Nord CE
Article: ANAEROBE. 2010;16(6):633-635

Antimicrobial susceptibility and heteroresistance in Chinese Clostridium difficile strains.

Huang H; Weintraub A; Fang H; Wu S; Zhang Y; Nord CE
Article: RESEARCH IN MICROBIOLOGY. 2010;161(5):346-354

Bacteroides fragilis RecA protein overexpression causes resistance to metronidazole.

Steffens LS; Nicholson S; Paul LV; Nord CE; Patrick S; Abratt VR
Article: APMIS. 2010;118(5):413-417

Screening for vancomycin-resistant enterococci: results of a survey in Stockholm.

Fang H; Nord CE; Ullberg M
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2010;54(5):1811-1814

Effect of ceftaroline on normal human intestinal microflora.

Panagiotidis G; Bäckström T; Asker-Hagelberg C; Jandourek A; Weintraub A; Nord CE
Article: JOURNAL OF CHEMOTHERAPY. 2010;22(1):25-29

Antibiotic resistance patterns in gram-negative and gram-positive bacteria causing septicemia in newborns in León, Nicaragua: correlation with environmental samples.

Amaya E; Caceres M; Fanc H; Torres Ramirez A; Palmgren A-C; Nord CE; Weintraub A
Article: CLINICAL INFECTIOUS DISEASES. 2010;50 Suppl 1:S16-S23

Metronidazole is still the drug of choice for treatment of anaerobic infections.

Löfmark S; Edlund C; Nord CE
Article: CLINICAL MICROBIOLOGY AND INFECTION. 2009;15(12):1170-1173

Distinct ribotypes and rates of antimicrobial drug resistance in Clostridium difficile from Shanghai and Stockholm.

Huang H; Fang H; Weintraub A; Nord CE
Article: JOURNAL OF CLINICAL MICROBIOLOGY. 2009;47(11):3729-3731

Comparison of a commercial multiplex real-time PCR to the cell cytotoxicity neutralization assay for diagnosis of clostridium difficile infections.

Huang H; Weintraub A; Fang H; Nord CE
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2009;34(3):268-270

Prevalence of qnr determinants among extended-spectrum beta-lactamase-positive Enterobacteriaceae clinical isolates in southern Stockholm, Sweden.

Fang H; Huang H; Shi Y; Hedin G; Nord CE; Ullberg M
Article: CURRENT MEDICAL RESEARCH AND OPINION. 2009;25(6):1461-1467

Levofloxacin versus azithromycin on the oropharyngeal carriage and selection of antibacterial- resistant streptococci in the microflora of healthy adults.

Nord CE; Peterson J; Ambruzs M; Fisher AC
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2009;53(6):2455-2462

P1A recombinant beta-lactamase prevents emergence of antimicrobial resistance in gut microflora of healthy subjects during intravenous administration of ampicillin.

Tarkkanen A-M; Heinonen T; Jõgi R; Mentula S; van der Rest ME; Donskey CJ; Kemppainen T; Gurbanov K; Nord CE
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2009;33(4):339-342

Clostridium difficile infections in a Shanghai hospital: antimicrobial resistance, toxin profiles and ribotypes.

Huang H; Wu S; Wang M; Zhang Y; Fang H; Palmgren A-C; Weintraub A; Nord CE
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2009;33(3):272-275

In vitro activity of nadifloxacin against several Gram-positive bacteria and analysis of the possible evolution of resistance after 2 years of use in Germany.

Alba V; Urban E; Angeles Dominguez M; Nagy E; Nord C-E; Palacín C; Vila J
Article: NUTRITION JOURNAL. 2009;8:4

Effect of supplement with lactic-acid producing bacteria on fatigue and physical activity in patients with chronic fatigue syndrome.

Sullivan A; Nord CE; Evengård B
Article: CURRENT INFECTIOUS DISEASE REPORTS. 2009;11(1):3-6

Can metronidazole still be used for treatment of Clostridium difficile infections?

Huang H; Nord CE
Article: CLINICAL MICROBIOLOGY AND INFECTION. 2008;14(4):370-376

Genetic diversity of community-associated methicillin-resistant Staphylococcus aureus in southern Stockholm, 2000-2005.

Fang H; Hedin G; Li G; Nord CE
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2008;31(4):316-320

European surveillance study on antimicrobial susceptibility of Gram-positive anaerobic cocci.

Brazier J; Chmelar D; Dubreuil L; Feierl G; Hedberg M; Kalenic S; Könönen E; Lundgren B; Malamou-Ladas H; Nagy E; Sullivan A; Nord CE; ESCMID Study Group on Antimicrobial Resistance in
Article: CURRENT INFECTIOUS DISEASE REPORTS. 2007;9(4):263-264

When should probiotics be used in gastrointestinal infections?

Nord CE
Article: ACTA DERMATO-VENEREOLOGICA. 2007;87(3):246-254

Clinical and microbiological comparisons of isotretinoin vs. tetracycline in acne vulgaris.

Oprica C; Emtestam L; Hagströmer L; Nord CE
Article: CLINICAL MICROBIOLOGY AND INFECTION. 2007;13(1):106-108

Emergence of VanD-type vancomycin-resistant Enterococcus faecium in Stockholm, Sweden.

Fang H; Hedin G; Telander B; Li G; Nord CE
Article: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2006;28(6):497-502

Examination of cfiA-mediated carbapenem resistance in Bacteroides fragilis strains from a European antibiotic susceptibility survey.

Sóki J; Edwards R; Hedberg M; Fang H; Nagy E; Nord CE; ESCMID Study Group on Antimicrobial Resistance in
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2006;50(10):3375-3380

Effect of tigecycline on normal oropharyngeal and intestinal microflora.

Nord CE; Sillerström E; Wahlund E
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2006;58(3):627-631

Effect of dalbavancin on the normal intestinal microflora.

Nord CE; Rasmanis G; Wahlund E
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2006;50(4):1528-1530

Microflora changes with norfloxacin and pivmecillinam in women with recurrent urinary tract infection.

Norinder BS; Norrby R; Palmgren A-C; Hollenberg S; Eriksson U; Nord CE
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2006;38(5):327-331

Probiotic lactobacilli and bacteraemia in Stockholm.

Sullivan A; Nord CE
Article: ANAEROBE. 2005;11(3):137-143

Genetic basis of resistance in Propionibacterium acnes strains isolated from diverse types of infection in different European countries.

Oprica C; Löfmark S; Lund B; Edlund C; Emtestam L; Nord CE
Article: CLINICAL MICROBIOLOGY AND INFECTION. 2005;11(3):204-213

European surveillance study on the antibiotic susceptibility of Propionibacterium acnes.

Oprica C; Nord CE; ESCMID Study Group on Antimicrobial Resistance in
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2005;49(1):170-175

Ecological effects of perorally administered pivmecillinam on the normal vaginal microflora.

Sullivan A; Fianu-Jonasson A; Landgren B-M; Nord CE
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2004;48(10):3765-3772

Ertapenem pharmacokinetics and impact on intestinal microflora, in comparison to those of ceftriaxone, after multiple dosing in male and female volunteers.

Pletz MWR; Rau M; Bulitta J; De Roux A; Burkhardt O; Kruse G; Kurowski M; Nord CE; Lode H
Article: CLINICAL MICROBIOLOGY AND INFECTION. 2004;10(10):937-939

Rapid and sensitive diagnosis of Toxoplasma gondii infections by PCR.

Jalal S; Nord CE; Lappalainen M; Evengård B; ESCMID Study Group on Toxoplasmosis
Article: CLINICAL MICROBIOLOGY AND INFECTION. 2004;10(10):899-903

Reduced susceptibility to penicillin of viridans group streptococci in the oral cavity of patients with haematological disease.

Westling K; Julander I; Ljungman P; Heimdahl A; Thalme A; Nord CE
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2004;54(4):791-797

Effect of Lactobacillus F19 on the emergence of antibiotic-resistant microorganisms in the intestinal microflora.

Sullivan A; Johansson A; Svenungsson B; Nord CE
Article: APMIS. 2004;112(6):342-348

DNA extraction and PCR assays for detection of Toxoplasma gondii.

Edvinsson B; Jalal S; Nord CE; Pedersen BS; Evengård B; ECSMID Study Group on Toxoplasmosis
Article: JOURNAL OF CHEMOTHERAPY. 2004;16(3):227-229

In vitro activity of ABT-492 against anaerobic bacteria.

Sillerström E; Wahlund E; Nord CE
Article: ANAEROBE. 2004;10(3):155-164

Antibiotic-resistant Propionibacterium acnes on the skin of patients with moderate to severe acne in Stockholm.

Oprica C; Emtestam L; Lapins J; Borglund E; Nyberg F; Stenlund K; Lundeberg L; Sillerström E; Nord CE
Article: MICROBIAL DRUG RESISTANCE. 2004;10(3):255-263

Impact of ketolides on resistance selection and ecologic effects during treatment for respiratory tract infections.

Nord CE; Farrell DJ; Leclercq R
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2003;52(2):308-311

Lactobacillus acidophilus, Bifidobacterium lactis and Lactobacillus F19 prevent antibiotic-associated ecological disturbances of Bacteroides fragilis in the intestine.

Sullivan A; Barkholt L; Nord CE
Article: JOURNAL OF CHEMOTHERAPY. 2003;15(3):244-247

Effect of garenoxacin on eubacteria in the normal intestinal microflora when administered concomitantly with digoxin.

Nord CE; Meurling L; Russo RL; Bello A; Grasela DM; Gajjar DA
Article: CLINICAL MICROBIOLOGY AND INFECTION. 2003;9(6):475-488

Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe.

Hedberg M; Nord CE; ESCMID Study Group on Antimicrobial Resistance in
Article: CLINICAL MICROBIOLOGY AND INFECTION. 2003;9(5):397-405

Anaerobic bacteria commonly colonize the lower airways of intubated ICU patients.

Agvald-Ohman C; Wernerman J; Nord CE; Edlund C
Article: CLINICAL MICROBIOLOGY AND INFECTION. 2003;9(4):306-309

Will triclosan in toothpaste select for resistant oral streptococci?

Sullivan A; Wretlind B; Nord CE
Article: ANAEROBE. 2003;9(1):11-14

The micro-flora of the small bowel in health and disease.

Sullivan A; Törnblom H; Lindberg G; Hammarlund B; Palmgren A-C; Einarsson C; Nord CE
Article: CLINICAL MICROBIOLOGY AND INFECTION. 2003;9(1):65-68

Dientamoeba fragilis--a protozoal infection which may cause severe bowel distress.

Norberg A; Nord CE; Evengård B
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2002;37(12):1380-1385

Bovine anti-Helicobacter pylori antibodies for oral immunotherapy.

Casswall TH; Nilsson HO; Björck L; Sjöstedt S; Xu L; Nord CK; Borén T; Wadström T; Hammarström L
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2002;50(5):707-712

Single- and multiple-dose pharmacokinetics of linezolid and co-amoxiclav in healthy human volunteers.

Burkhardt O; Borner K; von der Höh N; Köppe P; Pletz MW; Nord CE; Lode H
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2002;50(5):625-627

Probiotics in human infections.

Sullivan A; Nord CE
Article: INFECTION. 2002;30(3):158-160

The fecal microflora of 1-3-month-old infants during treatment with eight oral antibiotics.

Bennet R; Eriksson M; Nord CE
Article: CLINICAL MICROBIOLOGY AND INFECTION. 2002;8(4):229-239

Ecological impact of the des-F(6)-quinolone, BMS-284756, on the normal intestinal microflora.

Nord CE; Gajjar DA; Grasela DM
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2002;37(2):215-221

Effects of lactic acid bacteria on the uptake and distribution of the food mutagen Trp-P-2 in mice.

Orrhage KM; Annas A; Nord CE; Brittebo EB; Rafter JJ
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2002;34(12):898-903

Single- and multiple-dose pharmacokinetics of oral moxifloxacin and clarithromycin, and concentrations in serum, saliva and faeces.

Burkhardt O; Borner K; Stass H; Beyer G; Allewelt M; Nord CE; Lode H
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2002;34(1):17-21

Impact of combinations of antineoplastic drugs on intestinal microflora in 9 patients with leukaemia.

Nyhlén A; Ljungberg B; Nilsson-Ehle I; Nord CE
Article: CLINICAL MICROBIOLOGY AND INFECTION. 2001;7(7):376-379

Effect of step-down therapy of ceftriaxone plus loracarbef versus parenteral therapy of ceftriaxone on the intestinal microflora in patients with community-acquired pneumonia.

Vogel F; Ochs HR; Wettich K; Kalich S; Nilsson-Ehle I; Odenholt I; Nord CE
Article: JOURNAL OF CHEMOTHERAPY. 2001;13(3):299-308

Effect of perorally administered pivmecillinam on the normal oropharyngeal, intestinal and skin microflora.

Sullivan A; Edlund C; Svenungsson B; Emtestam L; Nord CE
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2001;45(6):1860-1867

In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia.

Livermore DM; Carter MW; Bagel S; Wiedemann B; Baquero F; Loza E; Endtz HP; van Den Braak N; Fernandes CJ; Fernandes L; Frimodt-Moller N; Rasmussen LS; Giamarellou H; Giamarellos-Bourboulis E; Jarlier V; Nguyen J; Nord CE; Struelens MJ; Nonhoff C; Turnidge J; Bell J; Zbinden R; Pfister S; Mixson L; Shungu DL
Article: CLINICAL MICROBIOLOGY AND INFECTION. 2001;7(5):230-237

Ecological effects on the oro- and nasopharyngeal microflora in children after treatment of acute otitis media with cefuroxime axetil or amoxycillin-clavulanate as suspensions.

Lund B; Edlund C; Rynnel-Dagöö B; Lundgren Y; Sterner J; Nord CE
Article: ANAEROBE. 2001;7(2):67-70

Effect of Lactobacillus paracasei on intestinal colonisation of lactobacilli, bifidobacteria and Clostridium difficile in elderly persons

Sullivan Å; Palmgren AC; Nord CE
Article: JOURNAL OF CHEMOTHERAPY. 2001;13(1):47-51

Impact of gemifloxacin on the normal human intestinal microflora.

Barker PJ; Sheehan R; Teillol-Foo M; Palmgren AC; Nord CE
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2001;47(1):43-50

Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study.

Wiström J; Norrby SR; Myhre EB; Eriksson S; Granström G; Lagergren L; Englund G; Nord CE; Svenungsson B
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2001;33(12):899-903

Ecological effects of linezolid versus amoxicillin/clavulanic acid on the normal intestinal microflora.

Lode H; Von der Höh N; Ziege S; Borner K; Nord CE
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2000;46(5):741-749

Pharmacokinetics and comparative effects of telithromycin (HMR 3647) and clarithromycin on the oropharyngeal and intestinal microflora.

Edlund C; Alván G; Barkholt L; Vacheron F; Nord CE
Article: CLINICAL MICROBIOLOGY AND INFECTION. 2000;6(10):549-556

In vitro activity of evernimicin and selected antibiotics against methicillin-resistant staphylococci: a 24-country study.

Goering R; Nord CE; Hare R; Sabatelli F; Ziracin Susceptibility Testing Group
Article: INFECTION. 2000;28(5):272-277

Ecological disturbances in intestinal microflora caused by clinafloxacin, an extended-spectrum quinolone.

Oh H; Nord CE; Barkholt L; Hedberg M; Edlund C
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2000;46(4):603-612

Effect of supplements with lactic acid bacteria and oligofructose on the intestinal microflora during administration of cefpodoxime proxetil.

Orrhage K; Sjöstedt S; Nord CE
Article: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. 2000;19(8):635-637

In vitro activity of ABT-773 against anaerobic bacteria.

Sillerström E; Wahlund E; Nord CE
Article: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. 2000;19(7):548-550

Impact of moxifloxacin versus clarithromycin on normal oropharyngeal microflora.

Beyer G; Hiemer-Bau M; Ziege S; Edlund C; Lode H; Nord CE
Article: ANAEROBE. 2000;6(3):143-148

Prevalence and antimicrobial susceptibility of enterotoxigenic Bacteroides fragilis in children with diarrhoea in Nicaragua

Cáceres M; Zhang GM; Weintraub A; Nord CE
Article: CLINICAL MICROBIOLOGY AND INFECTION. 2000;6(4):175-177

Impact of treatment of Helicobacter pylori on the normal gastrointestinal microflora.

Adamsson I; Edlund C; Nord CE
Article: CLINICAL MICROBIOLOGY AND INFECTION. 2000;6(3):159-163

In-vitro susceptibility of anaerobic bacteria to GAR-936, a new glycylcycline.

Edlund C; Nord CE
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2000;32(6):627-632

Impact on human intestinal microflora of an Enterococcus faecium probiotic and vancomycin.

Lund B; Edlund C; Barkholt L; Nord CE; Tvede M; Poulsen RL
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2000;32(1):81-85

Comparative effects of moxifloxacin and clarithromycin on the normal intestinal microflora.

Edlund C; Beyer G; Hiemer-Bau M; Ziege S; Lode H; Nord CE
Article: CLINICAL MICROBIOLOGY AND INFECTION. 2000;6(3):158-163

In-vitro susceptibility of anaerobic bacteria to GAR-936, a new glycylcycline

Edlund C; Nord CE
Article: INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED. 1999;30(10):651-657

Material and design in haematogenous implant-associated infections in a rabbit model.

Johansson A; Lindgren JU; Nord CE; Svensson O
Article: INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED. 1999;30(9):587-590

Local plate infections in a rabbit model.

Johansson A; Lindgren JU; Nord CE; Svensson O
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 1999;44(5):629-640

Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients.

Adamsson I; Nord CE; Lundquist P; Sjöstedt S; Edlund C
Article: ARCHIVES OF ORAL BIOLOGY. 1999;44(10):789-793

Isolation of bacteria from cervical lymph nodes in patients with oral cancer.

Sakamoto H; Naito H; Ohta Y; Tanakna R; Maeda N; Sasaki J; Nord CE
Article: CLINICAL MICROBIOLOGY AND INFECTION. 1999;5(10):612-616

Association between bacterial colonization on the tumor, bacterial translocation to the cervical lymph nodes and subsequent postoperative infection in patients with oral cancer.

Sakamoto H; Sasaki J; Nord CE
Article: CLINICAL INFECTIOUS DISEASES. 1999;29(1):1-8

Bacteremia after oral surgery and antibiotic prophylaxis for endocarditis.

Hall G; Heimdahl A; Nord CE
Article: ANAEROBE. 1999;5(3-4):431-434

Identification of the metallo-β-lactamase gene from clinical isolates of Bacteroides fragilis

Fang H; Hedberg M; Edlund C; Nord CE
Article: JOURNAL OF CHEMOTHERAPY. 1999;11(2):90-92

In vitro activity of LY 333328 against anaerobic gram-positive bacteria.

Sillerström E; Wahlund E; Nord CE
Article: ANAEROBE. 1999;5(1):11-18

Characterization of beta-lactam-resistant Bacteroides fragilis isolates by use of PCR fingerprinting.

Fang H; Hedberg M; Edlund C; Jarstrand C; Fodor E; Nord CE
Article: JOURNAL OF CHEMOTHERAPY. 1999;11(1):50-53

Ecological effect of gatifloxacin on the normal human intestinal microflora.

Edlund C; Nord CE
Article: TECHNICAL REPORT SERIES - WORLD HEALTH ORGANIZATION, GENEVA. 1999;888:1-95

Evaluation of certain veterinary drug residues in food -: Fiftieth report of the Joint FAO/WHO Expert Committee on Food Additives

Applegren LE; Arnold D; Boisseau J; Boobis AR; Ellis RL; Livingston RC; McLean JG; MacNeil JD; Miller MA; Miterna ES; Palermo-Neto; Pintér A; Martinez JLR; Sinhaseni P; Soback S; Wells R; Cernigilia CE; Chamberlain P; Chernausek SD; Fuchs R; Good EAM; Hansen MK; Heitzman RJ; Herrman JL; Mitsumori K; Nord CE; Olsen P; Paakkanen J; Pronk MEJ; Ritter L; Roberts G; Roestal B; Sills RC; Sundlof S; Ungemach FR; Weber N
Article: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 1998;28(11):958-968

Sudden infant death syndrome and nitrogen metabolism: further development of a hypothesis.

Wiklund L; George M; Nord CE; Ronquist G; Saldeen T
Article: JOURNAL OF CLINICAL GASTROENTEROLOGY. 1998;27(2):138-142

The value of different detection methods of Helicobacter pylori during treatment.

Adamsson I; Nord CE; Sjöstedt S; Wikström B; Seensalu R
Article: JOURNAL OF CHEMOTHERAPY. 1998;10(4):280-284

In vitro activity of HMR 3647 against anaerobic bacteria.

Edlund C; Sillerström E; Wahlund E; Nord CE
Article: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. 1998;17(3):193-195

Comparative in vitro activity of BAY 12-8039 and five other antimicrobial agents against anaerobic bacteria.

Edlund C; Sabouri S; Nord CE
Article: ANAEROBE. 1998;4(1):29-33

Comparison of E test and agar dilution methods for determining antibiotic susceptibilities of anaerobic bacteria and viridans streptococci isolated from blood.

Hall G; Heimdahl A; Nord CE
Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 1998;33(1):39-43

Prolonged and profound acid inhibition is crucial in Helicobacter pylori treatment with a proton pump inhibitor combined with amoxicillin.

Sjöstedt S; Sagar M; Lindberg G; Wikström B; Nord CE; Seensalu R
Article: CLINICAL INFECTIOUS DISEASES. 1997;25(3):729-732

Effect of vancomycin on intestinal flora of patients who previously received antimicrobial therapy.

Edlund C; Barkholt L; Olsson-Liljequist B; Nord CE
Article: INFECTION. 1997;25(3):154-158

Comparative effects of cefadroxil and phenoxymethylpenicillin on the normal oropharyngeal and intestinal microflora.

Adamsson I; Edlund C; Sjöstedt S; Nord CE
Article: TRANSPLANT INTERNATIONAL. 1997;10(6):432-438

Stool cultures obtained before liver transplantation are useful for choice of perioperative antibiotic prophylaxis.

Barkholt LM; Andersson J; Ericzon BG; Palmgren AC; Broomé U; Duraj F; Bergquist A; Herlenius G; Nord CE
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 1997;29(4):383-386

Comparative effects of levofloxacin and ofloxacin on the normal oral and intestinal microflora.

Edlund C; Sjöstedt S; Nord CE
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 1996;38(6):927-939

Effects of omeprazole and amoxycillin on the human oral and gastrointestinal microflora in patients with Helicobacter pylori infection.

Stark CA; Adamsson I; Edlund C; Sjösted S; Seensalu R; Wikström B; Nord CE
Article: ACTA PAEDIATRICA. 1996;85(9):1126-1128

Oral IgA-IgG treatment of chronic non-specific diarrhoea in infants and children.

Casswall TH; Hammarström L; Veress B; Nord CE; Bogstedt A; Brockstedt U; Dahlström KA
Article: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. 1996;15(8):646-649

Effects of prophylactic administration of cefaclor on transient bacteremia after dental extraction.

Hall G; Heimdahl A; Nord CE
Article: CLINICAL INFECTIOUS DISEASES. 1996;22(6):944-950

Resistance of the normal human microflora to mercury and antimicrobials after exposure to mercury from dental amalgam fillings.

Edlund C; Björkman L; Ekstrand J; Sandborgh-Englund G; Nord CE
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 1996;37(4):783-795

Elimination of bacteraemia after dental extraction: comparison of erythromycin and clindamycin for prophylaxis of infective endocarditis.

Hall G; Nord CE; Heimdahl A
Article: ANAEROBE. 1996;2(2):111-115

The role of penicillin-binding proteins for beta-lactam resistance in a beta-lactamase producing Bacteroides uniformis strain

Hedberg M; Bush K; Bradford PA; Bhachech N; Edlund C; Tuner K; Nord CE
Article: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 1996;28(5):507-512

Biapenem versus imipenem/cilastatin in the treatment of complicated intra-abdominal infections: report from a Swedish Study Group.

Brismar B; Akerlund JE; Sjöstedt S; Johansson C; Törnqvist A; Bäckstrand B; Bång H; Andåker L; Gustafsson PO; Darle N; Angerås M; Falk A; Tunevall G; Kasholm-Tengve B; Skau T; Nyström PO; Gasslander T; Hagelbäck A; Olsson-Liljequist B; Eklund AE; Nord CE
Article: ACTA OTO-LARYNGOLOGICA. 1995;115(5):689-696

Upregulated local cytokine production in recurrent tonsillitis compared with tonsillar hypertrophy.

Agren K; Andersson U; Nordlander B; Nord CE; Linde A; Ernberg I; Andersson J
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 1995;39(7):1458-1461

Purification and characterization of a new beta-lactamase from Bacteroides uniformis.

Hedberg M; Lindqvist L; Bergman T; Nord CE
Article: JOURNAL OF INFECTIOUS DISEASES. 1995;171(5):1230-1236

Development and characterization of a new model of hematogenous osteomyelitis in the rat.

Hienz SA; Sakamoto H; Flock JI; Mörner AC; Reinholt FP; Heimdahl A; Nord CE
Article: AMERICAN JOURNAL OF SURGERY. 1995;169(5A Suppl):S21-S26

Clinical trials of extended spectrum penicillin/beta-lactamase inhibitors in the treatment of intra-abdominal infections. European and North American experience.

Wilson SE; Nord CE
Article: DRUGS. 1995;49 Suppl 2:233-234

In vitro activity of new quinolones against anaerobic bacteria.

Nord CE; Lindmark A; Persson I
Article: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 1995;35(1):139-148

Meropenem versus imipenem/cilastatin in the treatment of intra-abdominal infections.

Brismar B; Malmborg AS; Tunevall G; Lindgren V; Bergman L; Mentzing LO; Nyström PO; Anséhn S; Bäckstrand B; Skau T
Article: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. 1995;14(1):18-24

Induction of beta-lactamase by cefoxitin in anaerobic intestinal microflora.

Stark C; Edlund C; Hedberg M; Nord CE
Article: INFECTIOUS DISEASES IN CLINICAL PRACTICE. 1995;4:S17-S25

TREATMENT OF INTRAABDOMINAL INFECTIONS - WORLDWIDE CLINICAL-TRIALS

NORD CE
Show more

All other publications

Review: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2014;58(8):4257-4263

Alternative strategies for proof-of-principle studies of antibacterial agents.

Dalhoff A; Weintraub A; Nord CE
Published paper: ANAEROBE. 2013;24:107-108

What is hot in the anaerobe literature? Clostridium difficile infections.

Nord CE
Review: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2009;34(6):516-522

Antimicrobial resistance in Clostridium difficile.

Huang H; Weintraub A; Fang H; Nord CE
Letter: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2009;33(4):386-387

Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit in León, Nicaragua.

Amaya E; Caceres M; Fang H; Ramirez AT; Palmgren AC; Nord CE; Weintraub A
Letter: SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES. 2009;41(2):158-159

Community acquired Clostridium difficile infection due to a moxifloxacin susceptible ribotype 027 strain.

Huang H; Weintraub A; Fang H; Nord CE
Letter: CLINICAL INFECTIOUS DISEASES. 2008;47(12):1606-1608

Molecular and clinical characteristics of Clostridium difficile infection in a University Hospital in Shanghai, China.

Huang H; Wu S; Wang M; Zhang Y; Fang H; Palmgren A-C; Weintraub A; Nord CE
Meeting abstract: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2008;12:E39

Antimicrobial Resistance Among Anaerobes - The European Experience

Nord CE
Meeting abstract: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2008;12:E451

Epidemiological Characterization of Clostridium difficile Strains in Shanghai, China

Huang H; Wu S; Wang M; Zhang Y; Fang H; Palmgren AC; Weintraub A; Nord CE
Meeting abstract: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2008;12:E22

Diagnosing Clostridium difficile-Associated Diseases: The State of the Art

Nord CE
Published paper: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2008;32(5):374-377

Virulence and antimicrobial resistance in clinical Enterococcus faecium.

Billström H; Lund B; Sullivan A; Nord CE
Letter: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2007;42(12):1514-1515

Increased number of Candida albicans in the faecal microflora of chronic fatigue syndrome patients during the acute phase of illness.

Evengård B; Gräns H; Wahlund E; Nord CE
Letter: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES. 2006;10(6):482-483

Emergence of methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin gene in Shanghai, China.

Li G-H; Zhang Y-Y; Wang F; Chen Y-J; Nord CE; Fang H
Published paper: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2006;28(4):292-296

Viridans group streptococci in blood culture isolates in a Swedish university hospital: antibiotic susceptibility and identification of erythromycin resistance genes.

Westling K; Julander I; Ljungman P; Jalal S; Nord CE; Wretlind B
Review: ANAEROBE. 2006;12(5-6):207-210

Antibiotic resistance in Propionibacterium acnes. Microbiological and clinical aspects.

Nord CE; Oprica C
Editorial comment: LANCET INFECTIOUS DISEASES. 2005;5(2):115-119

Lack of development of new antimicrobial drugs: a potential serious threat to public health.

Norrby SR; Nord CE; Finch R; European Society of Clinical Microbiology and Infe
Review: JOURNAL OF INTERNAL MEDICINE. 2005;257(1):78-92

Probiotics and gastrointestinal diseases.

Sullivan A; Nord CE
Review: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2002;20(5):313-319

The place of probiotics in human intestinal infections.

Sullivan A; Nord CE
Editorial comment: DRUGS. 2002;62(15):2235

Biapenem - A viewpoint by Carl Erik Nord

Nord CE
Published paper: CLINICAL INFECTIOUS DISEASES. 2002;35(Suppl 1):S47-S53

Selection of cefoxitin-resistant bacteroides thetaiotaomicron mutants and mechanisms involved in beta-lactam resistance.

Fang H; Edlund C; Nord CE; Hedberg M
Review: DERMATOLOGY NURSING / DERMATOLOGY NURSES' ASSOCIATION. 2002;14(4):242-246

Overview of treatments for acne.

Oprica C; Emtestam L; Nord CE
Review: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2002;19(5):361-370

New findings in beta-lactam and metronidazole resistant Bacteroides fragilis group.

Fang H; Edlund C; Hedberg M; Nord CE
Review: LANCET INFECTIOUS DISEASES. 2001;1(2):101-114

Effect of antimicrobial agents on the ecological balance of human microflora.

Sullivan A; Edlund C; Nord CE
Published paper: CLINICAL MICROBIOLOGY AND INFECTION. 2001;7 Suppl 5:37-41

The evaluation and prediction of the ecologic impact of antibiotics in human phase I and II trials.

Edlund C; Nord CE
Review: INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS. 2000;16(3):191-197

Development and persistence of multi-resistance to antibiotics in bacteria; an analysis and a new approach to this urgent problem.

van der Waaij D; Nord CE
Published paper: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2000;46 Suppl 1:41-48

Effect on the human normal microflora of oral antibiotics for treatment of urinary tract infections.

Edlund C; Nord CE
Review: JOURNAL OF CHEMOTHERAPY. 2000;12(1):5-16

Microbial ecology and treatment of Helicobacter pylori infections: review.

Adamsson I; Edlund C; Nord CE
Review: DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH. 2000;26(3):95-111

Bifidobacteria and lactobacilli in human health.

Orrhage K; Nord CE
Published paper: ACTA PAEDIATRICA, INTERNATIONAL JOURNAL OF PAEDIATRICS, SUPPLEMENT. 1999;88(430):47-57

Factors controlling the bacterial colonization of the intestine in breastfed infants.

Orrhage K; Nord CE
Review: INFECTION. 1999;27(3):166-172

Use of newer quinolones for the treatment of intraabdominal infections: focus on clinafloxacin.

Nord CE
Review: INFECTION. 1999;27(2):136-147

Monobactams and carbapenems for treatment of intraabdominal infections.

Brismar B; Nord CE
Published paper: DRUGS. 1999;58 Suppl 2:65-70

Effect of quinolones on intestinal ecology.

Edlund C; Nord CE
Published paper: CLINICAL INFECTIOUS DISEASES. 1998;27(3):471-473

Entamoeba gingivalis in human immunodeficiency virus type 1-infected patients with periodontal disease.

Lucht E; Evengård B; Skott J; Pehrson P; Nord CE
Published paper: CLINICAL INFECTIOUS DISEASES. 1997;25 Suppl 2:S270-S271

Role of penicillin-binding proteins in resistance of Bacteroides fragilis group species to beta-lactam drugs.

Hedberg M; Nagy E; Nord CE
Editorial comment: INFECTION. 1997;25(4):195-196

Ecological aspects of antimicrobial treatment of Helicobacter pylori infections.

Einarsson C; Nord CE
Published paper: CLINICAL INFECTIOUS DISEASES. 1996;23 Suppl 1:S15-S18

In vitro activity of quinolones and other antimicrobial agents against anaerobic bacteria.

Nord CE
Review: JOURNAL OF CHEMOTHERAPY. 1996;8(5):331-341

Antimicrobial treatment of periodontal diseases disturbs the human ecology: a review.

Edlund C; Hedberg M; Nord CE
Review: ZENTRALBLATT F�R BAKTERIOLOGIE : INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY. 1996;283(4):431-465

Problems and priorities for controlling opportunistic pathogens with new antimicrobial strategies; an overview of current literature.

Araneo BA; Cebra JJ; Beuth J; Fuller R; Heidt PJ; Midvedt T; Nord CE; Nieuwenhuis P; Manson WL; Pulverer G; Rusch VC; Tanaka R; van der Waaij D; Walker RI; Wells CL
Review: JOURNAL OF CHEMOTHERAPY. 1996;8(1):3-16

Beta-lactam resistance in anaerobic bacteria: a review.

Hedberg M; Nord CE
Published paper: MEDICAL MICROBIOLOGY LETTERS. 1996;5(6):295-304

Antimicrobial-resistant anaerobic bacteria in human infections

Hedberg M; Nord CE
Letter: BRITISH JOURNAL OF RHEUMATOLOGY. 1995;34(11):1095-1096

Lymphocyte reactivity to Clostridium perfringens antigens and toxoid in patients with arthritis.

Ström H; Johansson Borg A; Nord CE; Olhagen B; Möller E
Published paper: CLINICAL INFECTIOUS DISEASES. 1995;20 Suppl 2:S350-S351

Induction of beta-lactamase production in the anaerobic microflora by cefoxitin.

Stark C; Edlund C; Hedberg M; Nord CE
Review: CLINICAL INFECTIOUS DISEASES. 1995;20(6):1512-1524

The role of anaerobic bacteria in recurrent episodes of sinusitis and tonsillitis.

Nord CE
Review: DRUG SAFETY. 1995;12(5):305-313

Adverse effects of monobactams and carbapenems.

Alván G; Nord CE
Meeting abstract: GASTROENTEROLOGY. 1995;108(4):A792

ORAL IGA TREATMENT OF CHRONIC NONSPECIFIC DIARRHEA IN INFANTS AND CHILDREN

CASSWALL TH; HAMMARSTROM L; BOGSTEDT A; NORD CE; VERESS B; BROCKSTEDT U; DAHLSTROM KA
Published paper: JOURNAL OF CHEMOTHERAPY. 1995;7(1):42-44

Biapenem versus imipenem in the treatment of experimental intraabdominal infections.

Nord CE; Lahnborg G
Review: DRUGS. 1995;49 Suppl 2:81-85

Effect of quinolones on the human intestinal microflora.

Nord CE
Other: EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. 1995;14(1):61-64

Lack of effect of orally administered human serum immunoglobulin on the normal human oral and intestinal microflora.

Bogstedt AK; Nord CE; Hammarström L
Editorial comment: MICROBIAL DRUG RESISTANCE. 1995;1(2):101

Antibiotic resistance in respiratory tract pathogens: clinical and therapeutic consequences. Proceedings of a symposium. Stockholm, Sweden, October 31-November 1, 1994.
Other: INFECTION. 1995;23(1):51-54

Oral administration of a certain strain of live Escherichia coli for intestinal disorders? Artificial contamination and manipulation of the digestive tract--our poor GIT!
Show more

Articles

All other publications

News from KI

Events from KI